Article

Ophthalmology Times RWAP 2015

Guidelines for Case Study Submissions

Guidelines for Case Study Submissions

Residents are required to submit a Case Study to Ophthalmology Times (See attached Case Study Example) that includes a write-up of about 1,000 words on an ocular surface disease case, along with an abstract and PowerPoint Presentation (7 to 9 minutes in length) by Monday, August 17th, 2015.

The case study must focus on a pharmacological approach as it relates to an ocular surface disease patient.  Failure to meet this requirement will result in elimination from the program.

The case study and abstract should be written using a Word software application. The abstract should include an overview of the case study, noting the patient’s symptom(s), diagnosis, and treatment. Please remember to remove patients’ names from any clinical data that you submit (per HIPPA regulations).

The Case Study should include:

History

Describe in detail the case history of a patient who has presented at the resident’s institution. Include a review of the patient’s symptoms and medical history as they pertain to this particular case. Note possible complications and standard treatment methods.

Examination

Provide the results from a thorough ophthalmologic examination of the patient. Note any findings of particular significance to this case.

Discussion and diagnosis

Present a discussion of the problem this patient poses. The discussion should be specific and practical. The situation should let the OT Review Board and readers examine the problem and the problem-solving process and learn a lesson from others’ experience.

Conclusion

Explain the significance or importance of this case to ophthalmology.

References

References should follow text and be numbered consecutively by their order of appearance in the text. Journals should be referenced in the following format:

Massry GG, Hornblass A, Harrison W. Itraconazole in the treatment of orbital aspergillosis. Ophthalmology 1996;103:1467-1470.

 

Submit all materials to:

Tiffany Thompson

Coordinator, Custom Project Solutions

485F US 1 South- Suite 210

Iselin, NJ 08830

tthompson@advanstar.com

732.346.3060

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.